Equity Investing
Why Moderna, Inc. (MRNA) stock is gloomy today?
Moderna, Inc. (MRNA) stock announced third quarter 2021 financial results after which it became bearish today. MRNA stock saw a downtrend of 15.86% to drop
Tag: MRNA
Equity Investing
Gains May Be On The Menu For Moderna Inc. (MRNA)
In a news release on Monday, Moderna Inc. (MRNA) announced that Dr. Paul Burton would be taking over as head of the medical department as
Equity Investing
AstraZeneca (AZN) Sold its Moderna (MRNA)Stack for Over $1 Billion
AstraZeneca (AZN), a British drug company, sold 1.2 billion dollars worth of its shares in Moderna (mRNA). With 7.7% of the shares, the company was
